Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J During

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Journal of Neurochemistry|June 4, 2009
Regulation of the postnatal development of dopamine neurons of the substantia nigra in vivo by Akt/protein kinase BVincent Ries, Hsiao-Chun Cheng, Amy Baohan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
Regression of upper gastric cancer in mice by FHIT gene deliveryHideshi Ishii, Nicola Zanesi, Andrea Vecchione, et al.
Brain : a Journal of Neurology|May 15, 2008
Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsyFrancesco Noè, Allan-Hermann Pool, Jari Nissinen, et al.
Cell Calcium|September 24, 2016
Selected GRIN2A mutations in melanoma cause oncogenic effects that can be modulated by extracellular glutamateStacey Ann N D'mello, Wayne R Joseph, Taryn N Green, et al.
Neuropharmacology|January 14, 2014
Behavior of knock-in mice with a cocaine-insensitive dopamine transporter after virogenetic restoration of cocaine sensitivity in the striatumBrian O'Neill, Michael R Tilley, Dawn D Han, et al.
Molecular Neurodegeneration|June 15, 2007
Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Abeta levelsPatricia A Lawlor, Ross J Bland, Pritam Das, et al.
Science Translational Medicine|November 30, 2018
Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivityMartin Niethammer, Chris C Tang, An Vo, et al.
Plos One|December 31, 2009
Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in miceShu Lin, Yan-Chuan Shi, Ernie Yulyaningsih, et al.
Lancet (London, England)|June 26, 2007
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trialMichael G Kaplitt, Andrew Feigin, Chengke Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2007
The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damageHossein Aleyasin, Maxime W C Rousseaux, Maryam Phillips, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Journal of Neurochemistry|June 4, 2009
Regulation of the postnatal development of dopamine neurons of the substantia nigra in vivo by Akt/protein kinase BVincent Ries, Hsiao-Chun Cheng, Amy Baohan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
Regression of upper gastric cancer in mice by FHIT gene deliveryHideshi Ishii, Nicola Zanesi, Andrea Vecchione, et al.
Brain : a Journal of Neurology|May 15, 2008
Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsyFrancesco Noè, Allan-Hermann Pool, Jari Nissinen, et al.
Cell Calcium|September 24, 2016
Selected GRIN2A mutations in melanoma cause oncogenic effects that can be modulated by extracellular glutamateStacey Ann N D'mello, Wayne R Joseph, Taryn N Green, et al.
Neuropharmacology|January 14, 2014
Behavior of knock-in mice with a cocaine-insensitive dopamine transporter after virogenetic restoration of cocaine sensitivity in the striatumBrian O'Neill, Michael R Tilley, Dawn D Han, et al.
Molecular Neurodegeneration|June 15, 2007
Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Abeta levelsPatricia A Lawlor, Ross J Bland, Pritam Das, et al.
Science Translational Medicine|November 30, 2018
Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivityMartin Niethammer, Chris C Tang, An Vo, et al.
Plos One|December 31, 2009
Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in miceShu Lin, Yan-Chuan Shi, Ernie Yulyaningsih, et al.
Lancet (London, England)|June 26, 2007
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trialMichael G Kaplitt, Andrew Feigin, Chengke Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2007
The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damageHossein Aleyasin, Maxime W C Rousseaux, Maryam Phillips, et al.
Pageof 12